๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The future of new pure antiestrogens in clinical breast cancer

โœ Scribed by Alan E. Wakeling

Publisher
Springer US
Year
1993
Tongue
English
Weight
766 KB
Volume
25
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Insulin receptor substrate 1 is a target
Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells
โœ Michele Salerno; Diego Sisci; Loredana Mauro; Marina A. Guvakova; Sebastiano And ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 93 KB

The pure antiestrogen ICI 182,780 inhibits insulin-like growth factor (IGF)-dependent proliferation in hormoneresponsive breast cancer cells. However, the interactions of ICI 182,780 with IGF-I receptor (IGF-IR) intracellular signaling have not been characterized. Here, we studied the effects of ICI

Long-term inhibitory effect of the orall
Long-term inhibitory effect of the orally active and pure antiestrogen EM-800 on the growth of human breast cancer xenografts in nude mice
โœ Steeve Couillard; Claude Labrie; Sylvain Gauthier; Yves Merand; Shankar Mohan Si ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 174 KB ๐Ÿ‘ 2 views

The antiproliferative effect of the new antiestrogen EM-800 has been studied during 40 weeks of treatment on human breast carcinoma ZR-75-1 xenografts in ovariectomized nude mice supplemented with estrone (0.5 g, s.c. daily). At the daily 50 g (approximately 2.5 mg/kg) oral dose, EM-800 caused a com